|
gptkbp:instanceOf
|
gptkb:Cannabis
gptkb:psychoactive_compound
|
|
gptkbp:boilingPoint
|
157°C
|
|
gptkbp:CASNumber
|
1972-08-3
|
|
gptkbp:category
|
gptkb:metabolite
gptkb:phytocannabinoid
terpenophenolic compound
|
|
gptkbp:chemicalFormula
|
C21H30O2
|
|
gptkbp:decarboxylationProductOf
|
tetrahydrocannabinolic acid (THCA)
|
|
gptkbp:discoveredBy
|
gptkb:Raphael_Mechoulam
|
|
gptkbp:discoveredIn
|
1964
|
|
gptkbp:effect
|
euphoria
altered perception
increased appetite
|
|
gptkbp:eliminationHalfLife
|
1.6–59 hours
|
|
gptkbp:foundIn
|
gptkb:Cannabis
gptkb:Cannabis_indica
|
|
gptkbp:hasInChIKey
|
YXFVVABEGXRONW-UHFFFAOYSA-N
|
|
gptkbp:IUPACName
|
gptkb:(−)-trans-Δ⁹-tetrahydrocannabinol
|
|
gptkbp:legalStatus
|
varies by country
|
|
gptkbp:meltingPoint
|
157°C
|
|
gptkbp:metabolism
|
gptkb:11-hydroxy-THC
gptkb:THC-COOH
liver
|
|
gptkbp:molecularWeight
|
314.464 g/mol
|
|
gptkbp:otherName
|
gptkb:tetrahydrocannabinol
gptkb:THC
delta-9-THC
|
|
gptkbp:predecessor
|
cannabigerolic acid (CBGA)
tetrahydrocannabinolic acid (THCA)
|
|
gptkbp:routeOfAdministration
|
oral
inhalation
transdermal
sublingual
rectal
|
|
gptkbp:sideEffect
|
anxiety
paranoia
red eyes
dry mouth
impaired memory
|
|
gptkbp:smiles
|
CC1=CC(=C2C(=C1)CC(C3C2CCC4=CC(=CC(=C34)O)C)C)O
|
|
gptkbp:solubility
|
insoluble in water
soluble in lipids
soluble in alcohol
|
|
gptkbp:target
|
gptkb:CB1_receptor
gptkb:CB2_receptor
|
|
gptkbp:usedFor
|
gptkb:recreational_drug
medical marijuana
|
|
gptkbp:bfsParent
|
gptkb:(−)-trans-Δ⁹-tetrahydrocannabinol
gptkb:dronabinol
|
|
gptkbp:bfsLayer
|
7
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Δ⁹-THC
|